Results 161 to 170 of about 24,117 (172)

Memantine Extended Release (28 mg Once Daily): A Review of Its Use in Alzheimer’s Disease

Drugs, 2015
Greg L Plosker
exaly  

The Efficacy and Safety of Memantine for the Treatment of Alzheimer’s Disease

Expert Opinion on Drug Safety, 2018
Kenji Sakuma, Taro Kishi, Toshikazu Ikuta   +2 more
exaly  

Key Binding Interactions for Memantine in the NMDA Receptor

ACS Chemical Neuroscience, 2013
Henry Lester, Wesley Y Yu, Dennis A. Dougherty   +2 more
exaly  

Memantine Pharmacotherapy

Clinical Pharmacokinetics, 2007
Johannes Kornhuber, Udo Reulbach, Jens Wiltfang   +2 more
exaly  

Memantine in Moderate to Severe Alzheimer’s Disease: A Meta-Analysis of Randomised Clinical Trials

Dementia and Geriatric Cognitive Disorders, 2007
Bengt Winblad
exaly  

Memantine for Lewy Body Disorders: Systematic Review and Meta-Analysis

American Journal of Geriatric Psychiatry, 2015
Taro Kishi, Nakao Iwata, Shinji Matsunaga   +2 more
exaly  

Contribution of MATE1 to Renal Secretion of the NMDA Receptor Antagonist Memantine

Molecular Pharmaceutics, 2017
Jörg König, Fabian Müller
exaly  

Memantine for Prophylactic Treatment of Migraine Without Aura: A Randomized Double-Blind Placebo-Controlled Study

Headache, 2016
Mohammad Hossein Harirchian, Vajiheh Aghamollaii, Abbas Tafakhori   +2 more
exaly  

The Sustained Mood-Stabilizing Effect of Memantine in the Management of Treatment Resistant Bipolar Disorders: Findings From a 12-Month Naturalistic Trial

Journal of Affective Disorders, 2012
Giulia Serra, Gino Serra, Athanasios Koukopoulos   +2 more
exaly  

Efficacy and Safety of Memantine in Patients With Mild to Moderate Vascular Dementia

Stroke, 2002
Anne-Sophie Rigaud, Jean-Marc Orgogozo, Françoise Forette   +2 more
exaly